Naproxen sodium in short-term prophylaxis of pure menstrual migraine: Pathophysiological and clinical considerations

Neurological Sciences

Volumn 28, Issue SUPPL. 2, 2007, Pages

  Allais, G ^a   Bussone, G ^b   De Lorenzo, C ^a   Castagnoli Gabellari, I ^a   Zonca, M ^a   Mana, O ^a   Borgogno, P ^a   Acuto, G ^a   Benedetto, C ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Naproxen sodium; Prostaglandins; Pure menstrual migraine; Short term prophylaxis

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; NAPROXEN; PROSTAGLANDIN E2; THROMBOXANE B2;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MENSTRUAL CYCLE; MENSTRUAL MIGRAINE; MIGRAINE WITHOUT AURA; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; SHORT COURSE THERAPY;

6-KETOPROSTAGLANDIN F1 ALPHA; ADMINISTRATION, ORAL; ADULT; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MENSTRUATION DISTURBANCES; MIDDLE AGED; MIGRAINE DISORDERS; NAPROXEN; PREDICTIVE VALUE OF TESTS; THROMBOXANE B2; TIME FACTORS; TREATMENT OUTCOME;

EID: 34249297399     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-007-0783-3     Document Type: Article

References (21)

1. Parantainen J, Vapaatalo H, Hokkanen E (1985) Relevance of prostaglandins in migraine. Cephalalgia 5[Suppl 2]:93-97
2. Andersson PG, Hinge HH, Johansen O et al (1989) Doubleblind study of naproxen vs placebo in the treatment of acute migraine attacks. Cephalalgia 9:29-32
3. Welch KMA, Ellis DJ, Keenan PA (1985) Successful migraine prophylaxis with naproxen sodium. Neurology 35:1304-1310
4. Sargent J, Solbach P, Damasio H et al (1985) A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache. Headache 25:320-324
5. Behan PO, Connelly K (1986) Prophylaxis of migraine: A comparison between naproxen sodium and pizotifen. Headache 26:237-239
6. Bellavance AJ, Meloche JR (1990) A comparative study of naproxen sodium, pizotyline and placebo in migraine prophylaxis. Headache 30:710-715
7. Nattero G, Allais G, De Lorenzo C et al (1988) Menstrual migraine: New biochemical and psychological aspects. Headache 28:103-107
8. Nattero G, Allais G, De Lorenzo C et al (1989) Relevance of prostaglandins in true menstrual migraine. Headache 29:232-237
9. MacGregor A (1999) Migraine in women. Martin Dunitz Ltd, London
10. Hedman C, Winther K, Knudsen JB (1988) Platelet function in classic migraine during attack-free periods. Acta Neurol Scand 78:271-277
11. Mezei Z, Kis B, Gecse A et al (2000) Platelet arachidonate cascade of migraineurs in the interictal phase. Platelets 11:222-225
12. Vardi J, Flechter S, Alguati A et al (1983) Prostaglandin-E2 levels in the saliva of common migrainous women. Headache 23:59-61
13. Tuca JO, Planas JM, Paredella RP (1989) Increase in PGE2 and TXA2 in the saliva of common migraine patients. Action of calcium channel blockers. Headache 29:498-501
14. Dahl H (1986) Naproxen (Naprosyn) pharmacokinetics: Therapeutical relevance and tolerance profile. Cephalalgia 6[Suppl 4]:69-75
15. Sances G, Martignoni E, Fioroni L et al (1990) Naproxen sodium in menstrual migraine prophylaxis: A double-blind placebo controlled study. Headache 30:705-709
16. Headache Classification Committee of the International Headache Society (1988) Classification and Diagnostic Criteria for Headache Disorders, Cranial Neuralgias and Facial Pain. Cephalalgia 8[Suppl 7]:1-96
17. Nigam S, Becker R, Rosendhal U et al (1985) The concentrations o f 6-keto-PGF1a and TXB2 in plasma samples from patients with benign and malignant tumors of the breast. Prostaglandins 29:513-528
18. Warner TD, Giuliano F, Vojnovic I et al (1999) Nonsteroid drug selectivities for a cyclo-oxygenase-1 rather than cyclooxygenase- 2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc Natl Acad Sci 96:7563-7568
19. Steffel J, Lüscher T, Ruschitzka F, Tanner FC (2006) Cyclooxygenase-2 inhibition and coagulation. J Cardiovasc Pharmacol 47[Suppl 1]:S15-S20
20. Granella F, Sances G, Allais G et al (2004) Characteristics of menstrual migraine and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 24:707-716
21. Allais G, Bussone G, De Lorenzo C et al (2005) Advanced strategies of short-term prophylaxis in menstrual migraine: State of the art and prospects. Neurol Sci 26[Suppl 2]:S125-S129